INS and type 2 diabetes mellitus: It is likely that rare patients carrying a clinical diagnosis of T2D unknowingly bear heterozygous mild MIDY variants that contribute to disease pathogenesis despite receiving clinical treatment indistinguishable from others with T2D [22], including approaches in which exogenous insulin is not used [23,24].